Heart attack
-
Amgen’s cholesterol drug Repatha cut the risk of heart attack and stroke by over 20 percent
Mar 20, 2017News Hour: Amgen Inc’s $14,000 cholesterol drug Repatha cut the risk of heart attack and stroke by over 20 percent in patients with heart disease, but results from a highly anticipated study fell short of investor... -
Men may be at increased risk for a fatal heart attack after a major snowstorm hits
Feb 14, 2017News Hour: Men may be at increased risk for a fatal heart attack after a major snowstorm hits, a Canadian study suggests. Compared with periods without any snow, men were 16 percent more likely to have a... -
Bayer’s blood thinner Xarelto proved effective in preventing heart attacks and strokes in patients suffering from artery disease
Feb 9, 2017News Hour: Bayer’s best-selling blood-thinning drug Xarelto has also proved effective in preventing heart attacks and strokes in patients suffering from certain types of artery disease, the company said on Wednesday. The drug is approved to... -
Amgen Inc’s cholesterol drug Repatha significantly reduced the risk of heart attacks
Feb 3, 2017News Hour: Amgen Inc said its potent cholesterol fighter Repatha significantly reduced the risk of heart attacks, strokes and death in patients with heart disease, according to initial results of a large, eagerly-anticipated trial released on... -
Smokers under 50 face 8-fold higher heart attack risk
Nov 30, 2016News Hour: Smokers under 50 are eight times more likely than non-smokers of the same age to have a major heart attack, scientists said on Wednesday. The gap in risk between those who do and don’t...
